Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-270766
Filing Date
2024-12-04
Accepted
2024-12-04 16:52:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d837155d424b3.htm 424B3 287484
2 GRAPHIC g837155g79y84.jpg GRAPHIC 39489
  Complete submission text file 0001193125-24-270766.txt   343175
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283439 | Film No.: 241526821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)